Lupin to buy US-based Gavis Pharmaceuticals for $880 mn
Drug major Lupin Thursday said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.
Jul 23, 2015, 16:49 PM IST